Design of Cyclic Vinyl Sulfones as WRN Covalent Inhibitors from Noncovalent Binders
Journal of Medicinal Chemistry · 28.05.2026 · 69 (10) · 12430-12448
DOI: 10.1021/acs.jmedchem.6c00328 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Medicinal Chemistry, online erschienen am 29.04.2026. Verfasst von Justin A Caravella und 23 weiteren Autor:innen. Beteiligte Einrichtung: Nimbus Therapeutics, 22 Boston Wharf Rd. Floor 9, Boston, Massachusetts 02210, United States. Hauptthemen laut MEDLINE: Sulfones, Drug Design, Werner Syndrome Helicase, Antineoplastic Agents. Die Arbeit nennt 44 Literaturangaben. Gefördert von: Nimbus Wadjet project.
Abstract (Originalsprache)
Werner syndrome helicase (WRN) is a DNA damage response protein selectively required for the survival of tumors with high microsatellite instability (MSI-H). We identified a noncovalent WRN inhibitor 1 via an extensive screening and hit triage. Co-crystal structure of 1 with the WRN helicase domain revealed a unique mechanism of inhibition via stabilization of inactive protein conformation and led to identification of cysteine 727 as a target for covalent inhibition. Structure-based drug design (SBDD) and a computational workflow resulted in the discovery of cyclic vinyl sulfone 4 as a covalent WRN functional inhibitor with improved stability. Further optimization led to potent compound 26 demonstrating exquisite selectivity to WRN in cell proteomic profiling and strong in vivo efficacy in an MSI-H Xenograft tumor model with no effect in microsatellite stable xenograft tumors. Therefore, a proof of concept of synthetic lethal MSI-H tumor cell growth inhibition by covalent inhibitor 26 was achieved.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Nimbus Therapeutics, 22 Boston Wharf Rd. Floor 9, Boston, Massachusetts 02210, United States.
- Nuvisan ICB GmbH, Muellerstr. 178, 13353 Berlin, Germany.
- Pharmaron UK Ltd., West Hill Innovation Park, Hertford Road, Hoddesdon EN11 9FH, U.K.
- Department of Medicinal Chemistry, Pharmaron Beijing Co., Ltd., Beijing 100176, China.
ORCID-Profile: Jennifer A Borthwick, Alan P Graves, Scott D Edmondson, Derun Li
Förderung
- Nimbus Wadjet project
Zitieren
APA
Caravella, J. A., Toms, A. V., Sitnikov, N., Bartels, F., Svensson, R., O'Hagan, S. J., Borthwick, J. A., Campos, S., Yin, Y., Zhao, X., Li, L., Liu, R., Talbot, E., Kong, H., Adolf Freund, R. R., Browning, B., Genung, N. E., Carreiro, S., Brennan, D., …, & Li, D. (2026). Design of Cyclic Vinyl Sulfones as WRN Covalent Inhibitors from Noncovalent Binders. Journal of Medicinal Chemistry, 69(10), 12430-12448. https://doi.org/10.1021/acs.jmedchem.6c00328
Vancouver
Caravella JA, Toms AV, Sitnikov N, Bartels F, Svensson R, O'Hagan SJ, et al. Design of Cyclic Vinyl Sulfones as WRN Covalent Inhibitors from Noncovalent Binders. Journal of Medicinal Chemistry. 2026;69(10):12430-12448. doi:10.1021/acs.jmedchem.6c00328
BibTeX
@article{Caravella2026,
author = {Caravella, Justin A and Toms, Angela V and Sitnikov, Nikolay and Bartels, Florian and Svensson, Robert and O'Hagan, Suzanne Jacques and Borthwick, Jennifer A and Campos, Sebastien and Yin, Ying and Zhao, Xingwang and Li, Lezhen and Liu, Ronggang and Talbot, Eric and Kong, Hanchu and Adolf Freund, Robert Reinhold and Browning, Beth and Genung, Nathan E and Carreiro, Samantha and Brennan, Debra and Graves, Alan P and Loh, Christine and Tummino, Peter and Edmondson, Scott D and Li, Derun},
title = {Design of Cyclic Vinyl Sulfones as WRN Covalent Inhibitors from Noncovalent Binders},
journal = {Journal of Medicinal Chemistry},
year = {2026},
volume = {69},
number = {10},
pages = {12430--12448},
doi = {10.1021/acs.jmedchem.6c00328}
}
EUVIMED